Clinical Trials in Pittsburgh

Showing 12821-12840 of 18,076 trials

Muscle Lipid and Insulin Resistance in the Elderly

NCT00765505

This project will provide novel information concerning the ability of exercise to enhance the capacity for oxidative metabolism of fatty acids and improve insulin resistance in older adults who are at high risk for the development of type 2 diabetes. Ultimately this may help identify mechanisms and therapeutic targets implicated in skeletal muscle metabolic dysregulation. The proposed study is to conduct a randomized controlled exercise training intervention trial in older men and women. In addition, the response to exercise in these subjects will be compared to those of highly endurance-trained, age-matched athletes.

Obesity

University of Pittsburgh92 participantsStarted Jul 2004

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study

NCT00877006

The primary objective of the study is to compare the complete response (CR) rate of bendamustine and rituximab (BR) with that of standard treatment regimens of either rituximab, cyclophosphamide, vincristine, and prednisone (R-CVP) or rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with advanced, indolent non-Hodgkin's lymphoma (NHL) or mantle cell lymphoma (MCL).

Non-Hodgkin's LymphomaMantle Cell Lymphoma

Teva Branded Pharmaceutical Products R&D, Inc.447 participantsStarted Apr 2009

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Corona, California, United States +125 more locations

Muscle Lipid and Insulin Resistance in the Elderly

Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study

Find Trials by Condition in Pittsburgh

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD

Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)

Environmental Triggers Of Cardiometabolic Disease

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Expanded Access Program of Ponatinib

Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)

AngioDefender Versus Brachial Artery Ultrasound Imaging

Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis

A Phase II Trial of Regadenoson in Sickle Cell Anemia

Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes

DNS-7801 vs. Placebo in Parkinson's Disease

Safety and Effectiveness Study of the AcuFocus Corneal Inlay ACI 7000PDT in Presbyopes

A Study of DCC-2701 in Participants With Advanced Solid Tumors

Ph II Study of Perifosine for Patients With Carcinoma of the Kidney

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

Using the Canary Breathing System for Panic Disorder Patients